Peutz-Jeghers Syndrome (PJS) supports researchers conducting scientific studies or clinical trials to improve diagnosis, clarify disease mechanisms, and advance new or better therapies for this rare condition.
Funder: National Organization for Rare Disorders
Due Dates: January 19, 2027, at 11:59 p.m. PT (Letter of Intent / Initial Application)
Funding Amounts: One grant up to $152,000 USD for a one- or two-year project
Summary: Supports scientific and clinical research on Peutz-Jeghers syndrome to improve diagnosis, understand disease mechanisms, and advance therapy.
Key Information: Open to U.S. and international researchers, with strong preference for faculty-level or senior scientists at academic or nonprofit institutions or foundations.
The National Organization for Rare Disorders (NORD), with donations from the Peutz-Jeghers syndrome community, supports scientific and clinical studies related to PJS. This rare genetic condition is associated with variants in the STK11/LKB1 gene, gastrointestinal polyps, distinctive skin and mucous membrane pigmentation, and increased cancer risk. The opportunity is part of NORD’s Rare Disease Research Grants Program, established in 1989.
The grant funds the initiation of research studies or clinical trials designed to improve diagnosis, clarify underlying disease mechanisms, or advance therapy. Ideally, the research will have the potential to lead to a new or better therapy. Results may support subsequent funding from the NIH, FDA, other funding agencies, or a corporate sponsor. Selection emphasizes scientific merit and high-impact research.